𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ropinirole prolonged release: a guide to its use in Parkinson’s disease

✍ Scribed by &NA;

Book ID
121499759
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2009
Tongue
English
Weight
102 KB
Volume
25
Category
Article
ISSN
1172-0360

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PREPARED: Comparison of prolonged and im
PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease
✍ Fabrizio Stocchi; Luigi Giorgi; Brian Hunter; Anthony HV Schapira 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB

## Abstract Background: PREPARED was a randomized, parallel‐group, double‐blind, multicenter study to evaluate the efficacy of adjunctive ropinirole prolonged release (PR) versus immediate release (IR) in patients with advanced Parkinson's disease (PD). Methods: Patients received once‐daily PR (2–2

An open-label conversion study of pramip
An open-label conversion study of pramipexole to ropinirole prolonged release in Parkinson's disease
✍ Kelly E. Lyons; Rajesh Pahwa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

## Abstract Ropinirole prolonged release (PR) is a once daily oral dopamine agonist approved for the treatment of Parkinson's disease (PD). The goal of this 4 week, open‐label study was to determine the most effective conversion ratio with the fewest adverse effects (AEs) when switching from pramip